<p>Mike Stuart, the General Counsel of the U.S. Department of Health and Human Services (HHS), stated that his office has referred the &#34;affordable weight loss drug&#34; supplier Hims &amp; Hers to the Department of Justice due to allegations that the company (which &#34;imitates&#34; the Novo Nordisk weight loss drug Wegovy) has violated the federal Food, Drug, and Cosmetic Act</p>

<p>Mike Stewart, the General Counsel of the U.S. Department of Health and Human Services, stated that Hims & Hers has been referred to the Department of Justice for allegedly violating the federal Food, Drug, and Cosmetic Act, with the company accused of "copying" Novo Nordisk's weight loss drug Wegovy</p>

Wallstreetcn

SPDR S&P Health

ALPS Medical Breakthrough

Defiance Daily Target 2X Long NVO ETF

VanEck Biotech ETF

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

iShares Global Healthcare

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

VG Health

Invesco Biotechnology & Genome ETF

Ark Genomic Revolution ETF

Direxion S&P Biotech Bear 3X

Hims & Hers Health

iShares US Healthcare Providers

Defiance Daily Target 2X Long HIMS ETF

iShares US Medical Devices

Health Care Select Sector SPDR

Defiance Leveraged Long +Income HIMS ETF

SPDR S&P Health Equip

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

News